Lipocine Stock Future Price Prediction

LPCN -  USA Stock  

USD 1.13  0.04  3.42%

Lipocine stock price prediction is an act of determining the future value of Lipocine shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Lipocine's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lipocine and does not consider all of the tangible or intangible factors available from Lipocine's fundamental data. We analyze noise-free headlines and recent hype associated with Lipocine, which may create opportunities for some arbitrage if properly timed.
Additionally, see Lipocine Basic Forecasting Models to cross-verify your projections.

Lipocine Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Lipocine based on different types of headlines from major news networks to social media. The Lipocine stock price prediction module provides an analysis of price elasticity to changes in media outlook on Lipocine over a specific investment horizon. Using Lipocine hype-based prediction, you can estimate the value of Lipocine from the perspective of Lipocine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lipocine using Lipocine's options and short interest. It helps to benchmark the overall future attitude of investors towards Lipocine using crowd psychology based on the activity and movement of Lipocine's stock price.
Lipocine Current Ratio is quite stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 3.95. Sales per Share is expected to rise to 0.005542 this year, although the value of Cash Flow Per Share will most likely fall to (0.30) .

Lipocine Implied Volatility

    
  0.0  
Lipocine's implied volatility exposes the market's sentiment of Lipocine stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lipocine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lipocine stock will not fluctuate a lot when Lipocine's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Lipocine. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Lipocine to buy its stock at a price that has no basis in reality. In that case, they are not buying Lipocine because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lipocine after-hype prediction price

    
  $ 1.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Lipocine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Lipocine in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.091.794.84
Details
Naive
Forecast
LowNext ValueHigh
0.0218281.094.14
Details
3 Analysts
Consensus
LowTarget PriceHigh
2.503.756.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-0.23-0.18-0.12
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lipocine. Your research has to be compared to or analyzed against Lipocine's peers to derive any actionable benefits. When done correctly, Lipocine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Lipocine.

Lipocine After-Hype Price Prediction Density Analysis

As far as predicting the price of Lipocine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lipocine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Lipocine, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Lipocine Estimiated After-Hype Price Volatility

In the context of predicting Lipocine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lipocine's historical news coverage. Lipocine's after-hype downside and upside margins for the prediction period are 0.06 and 4.18, respectively. We have considered Lipocine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.13
27th of November 2021
1.13
After-hype Price
4.18
Upside
Lipocine is very risky asset. Analysis and calculation of next after-hype price of Lipocine is based on 3 months time horizon.

Lipocine Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Lipocine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lipocine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lipocine, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.23  3.05  0.00   0.01  7 Events / Month1 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.131.130.00 
30,500  

Lipocine Hype Timeline

Lipocine is now traded for 1.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Lipocine forecasted not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis forecasted to be very small whereas the daily expected return is now at -0.23%. The volatility of relative hype elasticity to Lipocine is about 10166.67%. The volatility of related hype on Lipocine is about 10166.67% with expected price after next announcement by competition of 1.12. The book value of the company was now reported as 0.48. The company recorded a loss per share of 0.28. Lipocine had not issued any dividends in recent years. The entity had 1:100 split on the 25th of July 2013. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 7 days.
Additionally, see Lipocine Basic Forecasting Models to cross-verify your projections.

Lipocine Related Hype Analysis

Having access to credible news sources related to Lipocine's direct competition is more important than ever and may enhance your ability to predict Lipocine's future price movements. Getting to know how Lipocine rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lipocine may potentially react to the hype associated with one of its peers.

Lipocine Additional Predictive Modules

Most predictive techniques to examine Lipocine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lipocine using various technical indicators. When you analyze Lipocine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lipocine Predictive Indicators

The successful prediction of Lipocine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lipocine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lipocine based on analysis of Lipocine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lipocine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lipocine's related companies.
 2010 2019 2020 2021 (projected)
PPandE Turnover9.114.6313.1711.93
Long Term Debt to Equity0.730.610.70.76

Story Coverage note for Lipocine

The number of cover stories for Lipocine depends on current market conditions and Lipocine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lipocine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lipocine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Lipocine Short Properties

Lipocine's future price predictability will typically decrease when Lipocine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lipocine often depends not only on the future outlook of the potential Lipocine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipocine's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.19%
Short Percent Of Float4.29%
Float Shares86.08M
Shares Short Prior Month3.5M
Average Daily Volume Last 10 Day586.88k
Average Daily Volume In Three Month807.18k
Date Short Interest13th of August 2021
Additionally, see Lipocine Basic Forecasting Models to cross-verify your projections. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.